Document Detail


Effect of antenatal glucocorticoid administered in a single dose on the incidence of respiratory distress syndrome in premature infants.
MedLine Citation:
PMID:  581109     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors administered glucocorticoid in the cases of 116 pregnant women admitted with premature delivery beginning between 28--36 weeks of gestation to prevent respiratory distress syndrome (RDS). Prednisolone-sodium succinate (Di-Adreson F. Organon) was given intramuscularly in a single dose of 100 mg. 314 infants born before introduction of the corticosteroid prevention on the 28--36 weeks of gestation whose mothers had not been given corticosteroid served as a control group. The frequency of RDS on the treated group was 8,62% while 101 of 314 infants on the control group showed RDS (32,16%). Number of infants of hyaline membrane disease was 3 and 40, respectively. A close correlation could be observed between the interval lasting from therapy to delivery and RDS incidence. In infants born within 24 hours after administration of Di-Adreson F. aquosum injection RDS developed in 58,33% while in those born within 24--48 hours RDS was diagnosed only on 3 cases (8,57%). No RDS was found in babies born after 2 days following the therapy. There were no significant differences between treated and control groups in Apgar scores and the mean weights of infants. These findings seem to suggest that 100 mg of prednisolonesodium succinate administered in a single dose significantly reduces the incidence of RDS in premature infants.
Authors:
I M Szabó; I F Csaba; P F Novák; I A Drozgyik
Related Documents :
10796379 - Prophylactic versus selective use of surfactant for preventing morbidity and mortality ...
22958649 - Infant mortality in the flemish region of belgium 1999-2008: a time-to-event analysis.
2642259 - The severity of rds during the first two neonatal days in relationship to fluid intake.
19490659 - Cost-utility analysis of palivizumab in italy: results from a simulation model in the p...
18420969 - Longitudinal evaluation of airway function 21 years after preterm birth.
22753129 - Healthcare providers' perceptions of breastfeeding peer counselors in the neonatal inte...
21427309 - Role of abdominal sonography in the preoperative diagnosis of extrahepatic biliary atre...
1948639 - Longevity gains continue.
3552619 - Studies on lhrh and physiological fluid amino acids in human colostrum and milk.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Zeitschrift für Geburtshilfe und Perinatologie     Volume:  182     ISSN:  0300-967X     ISO Abbreviation:  Z Geburtshilfe Perinatol     Publication Date:  1978 Jun 
Date Detail:
Created Date:  1978-10-25     Completed Date:  1978-10-25     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0326205     Medline TA:  Z Geburtshilfe Perinatol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  219-23     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Humans
Hyaline Membrane Disease / prevention & control
Infant, Newborn
Obstetric Labor, Premature
Prednisolone / therapeutic use*
Pregnancy
Prenatal Care
Respiratory Distress Syndrome, Newborn / prevention & control*
Chemical
Reg. No./Substance:
50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vivo resistance and in vitro cellular reactivity against lymphosarcoma cells in immunized mice.
Next Document:  Plasma levels of growth hormone in female rats of different ages.